Trends and Sex Differences in Hospitalizations and Mortality in Parkinson's Disease in Spain (2010-2019): A Nationwide Population-Based Study

• Published in: Journal of clinical medicine 2023-01, Vol.12 (3), p.902
• Main Authors: Gómez-Mayordomo, Víctor, Alonso-Frech, Fernando, Hernández-Barrera, Valentín, Carabantes-Alarcon, David, Zamorano-León, José J, Lopez-de-Andrés, Ana, Jiménez-García, Rodrigo
• Format: Article
• Language: English
• Subjects: Age; Clinical medicine; Comorbidity; Hospitalization; Hospitals; Mortality; Parkinson's disease; Patient admissions; Population-based studies; Regression analysis; Statistical analysis; Trends
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm12030902

The incidence of hospitalizations of Parkinson´s disease (PD) in Spain suffered a steady rise from 1997 to 2012. However, data on the trends during the following decade (2010-2019) are lacking. Hospital admissions with a primary and secondary diagnosis of PD were selected using the Spanish National Hospital Discharge Database (SNHDD) for the period 2010-2019. The primary endpoint was the incidence of hospitalizations and in-hospital mortality, stratified in biannual periods. The incidence of PD hospitalizations increased progressively over time from 81.25 cases in 2010-2011 to 94.82 cases in 2018-2019 per 100,000 inhabitants. Male sex, age and comorbidity also increased progressively in PD inpatients. PD as a comorbid condition presented a higher increment (annual percentage of change, APC +1.71%, < 0.05) than PD as the main reason of hospitalization (APC +1.26%, < 0.05). In the multivariate regression model, factors associated with mortality were male sex (OR = 1.15, 95% CI 1.01-1.35), age (>80 years, OR = 12.76, 95% CI 3.96-29.64) and comorbidity (Charlson index ≥ 2, OR 1.77, 95% CI 1.69-1.85). Adjusted mortality by age, sex, comorbidity and diagnostic position remained stable. In conclusion, PD hospitalizations in Spain have increased, with a parallel increment in mean age, male sex and higher comorbidities. However, adjusted mortality remains unchanged. The burden of this disease may increase the complexity and costs of hospital care in the future.